Literature DB >> 18724146

Topographic evaluation of relatives of patients with keratoconus.

Farid Karimian1, Shiela Aramesh, Hossein Mohammad Rabei, Mohammad Ali Javadi, Nasrin Rafati.   

Abstract

PURPOSE: To evaluate topographic corneal changes in relatives of patients with keratoconus (KCN).
METHODS: In a prospective study, 300 eyes of 150 relatives of 45 patients with KCN were evaluated. Complete slit-lamp examination, refraction, and corneal topography were performed for all eyes. The topographic indices for diagnosis of KCN were from Rabinowitz criteria.
RESULTS: The study included 84 (56%) female and 66 (44%) male subjects. Mean age was 32.4 +/- 15 years (range, 16-83 years). KCN was diagnosed in 14% of the subjects and another 7.3% were suspicious for KCN. The overall prevalence of astigmatism was 58%, including 42.1% in the KCN group, 66.7% in the KCN suspect group, and 49.6% in the healthy group. Thirty-one eyes had high regular astigmatism (>1.5 D) including 17 (54.8%) in the KCN group and 14 (45.2%) in the healthy group. Oblique astigmatism was seen in 33 (11%) eyes, including 34.2% in the KCN group, 47.6% in the suspicious KCN group, and 4.6% in the healthy group.
CONCLUSIONS: Relatives of patients with KCN have a high prevalence of undiagnosed KCN. Corneal topography is important for the diagnosis of KCN and KCN suspects in family members of patients with KCN. Therefore, keratorefractive surgery should be considered cautiously in these individuals.

Entities:  

Mesh:

Year:  2008        PMID: 18724146     DOI: 10.1097/ICO.0b013e31816f5edc

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  22 in total

1.  Presence of Fleischer ring and prominent corneal nerves in keratoconus relatives and normal controls.

Authors:  Ágnes Kriszt; Gergely Losonczy; András Berta; Lili Takács
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

2.  Corneal topographic changes in healthy siblings of patients with keratoconus.

Authors:  Mohammad Reza Besharati; Mohammad Reza Shoja; Masoud Reza Manaviat; Maryam Kheirandish; Maasome Zare Rad
Journal:  Int J Ophthalmol       Date:  2010-03-18       Impact factor: 1.779

3.  Videokeratoscopic indices in relation to epidemiological exposure to keratoconus.

Authors:  Jose Luis Mato; Isabel Lema; Elío Díez-Feijoo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-07       Impact factor: 3.117

4.  The Genetics of Keratoconus: A Review.

Authors:  Joshua Wheeler; Michael A Hauser; Natalie A Afshari; R Rand Allingham; Yutao Liu
Journal:  Reprod Syst Sex Disord       Date:  2012-06-03

Review 5.  Pediatric keratoconus - Current perspectives and clinical challenges.

Authors:  Venugopal Anitha; Murugesan Vanathi; Anita Raghavan; Revathi Rajaraman; Meenakshi Ravindran; Radhika Tandon
Journal:  Indian J Ophthalmol       Date:  2021-02       Impact factor: 1.848

6.  The genetics of keratoconus.

Authors:  Dorota M Nowak; Marzena Gajecka
Journal:  Middle East Afr J Ophthalmol       Date:  2011-01

7.  Contact lens visual rehabilitation in keratoconus and corneal keratoplasty.

Authors:  Yelda Ozkurt; Mehmet Atakan; Tugba Gencaga; Sezen Akkaya
Journal:  J Ophthalmol       Date:  2012-01-15       Impact factor: 1.909

8.  Case-control association between CCT-associated variants and keratoconus in a Saudi Arabian population.

Authors:  Khaled K Abu-Amero; Inas Helwa; Abdulrahman Al-Muammar; Shelby Strickland; Michael A Hauser; R Rand Allingham; Yutao Liu
Journal:  J Negat Results Biomed       Date:  2015-06-04

Review 9.  Pathogenesis of Keratoconus: The intriguing therapeutic potential of Prolactin-inducible protein.

Authors:  Rabab Sharif; Sashia Bak-Nielsen; Jesper Hjortdal; Dimitrios Karamichos
Journal:  Prog Retin Eye Res       Date:  2018-07-13       Impact factor: 19.704

10.  Screening of the Seed Region of MIR184 in Keratoconus Patients from Saudi Arabia.

Authors:  Khaled K Abu-Amero; Inas Helwa; Abdulrahman Al-Muammar; Shelby Strickland; Michael A Hauser; R Rand Allingham; Yutao Liu
Journal:  Biomed Res Int       Date:  2015-08-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.